Emodin is a novel phosphatidylethanolamine anabolism inhibitor that reprograms lipid metabolism to overcome 5-fluorouracil resistance in colorectal cancer

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 99a625940b39ebe7-IAD IP: 47.97.18.252 UTC time: 2025-11-06T17:00:23+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4